These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6185539)

  • 1. The ontogenetic mouse brain model employed in the characterization of antibrain antibodies in multiple sclerosis.
    Ryberg B
    J Neuroimmunol; 1983 Feb; 4(1):9-15. PubMed ID: 6185539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin characterization by bacterial absorption of antibrain antibodies in multiple sclerosis.
    Ryberg B; Kronvall G
    Eur Neurol; 1981; 20(5):374-9. PubMed ID: 7285987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple specificities of antibrain antibodies in multiple sclerosis and chronic myelopathy.
    Ryberg B
    J Neurol Sci; 1978 Oct; 38(3):357-82. PubMed ID: 731263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal study of antibrain antibodies in multiple sclerosis.
    Ryberg B
    J Neurol Sci; 1982 May; 54(2):263-70. PubMed ID: 6284884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different types of antibrain antibodies in multiple sclerosis. Studies employing myelin-deficient mutants of mice.
    Ryberg B; Baumann NA
    J Neurol Sci; 1983 Mar; 58(3):351-5. PubMed ID: 6842263
    [No Abstract]   [Full Text] [Related]  

  • 6. Intrathecal and extrathecal production of antibrain antibodies in multiple sclerosis.
    Ryberg B
    J Neurol Sci; 1980 Oct; 48(1):1-8. PubMed ID: 7420122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are anti-brain antibodies in multiple sclerosis directed to myelin basic protein? Studies employing the Shiverer mouse mutant.
    Ryberg B; Jacque C
    Acta Neurol Scand; 1986 Mar; 73(3):247-52. PubMed ID: 2424259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement-fixing antibrain antibodies in multiple sclerosis. Comparison of their occurrence in cerebrospinal fluid and serum.
    Ryberg B
    Acta Neurol Scand; 1976 Jul; 54(1):1-12. PubMed ID: 936972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibrain antibodies in multiple sclerosis. Relation to clinical variables.
    Ryberg B
    J Neurol Sci; 1982 May; 54(2):239-61. PubMed ID: 7097299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement-fixing antibrain antibodies in multiple sclerosis. A preliminary report.
    Laurell AB; Link H
    Acta Neurol Scand; 1972; 48(4):461-6. PubMed ID: 5072655
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple sclerosis: search for a serologic inhibitor.
    Ryberg B
    Acta Neurol Scand; 1980 Sep; 62(3):193-6. PubMed ID: 7211171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal autoantibodies derived from multiple sclerosis patients and control persons and their reactivities with antigens of the central nervous system.
    Uhlig H; Dernick R
    Autoimmunity; 1989; 5(1-2):87-99. PubMed ID: 2562390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Virus neutralizing and antibrain antibodies in multiple sclerosis and multiple encephalomyelitis].
    Zinchenko AP; Shamreĭ RK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(4):541-8. PubMed ID: 4301248
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistence of antibrain antibodies in cerebrospinal fluid during plasmapheresis for multiple sclerosis.
    Ryberg B; Pirskanen R
    Br Med J (Clin Res Ed); 1985 Sep; 291(6499):850-1. PubMed ID: 2996688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibrain antibodies in multiple sclerosis; study of the antibrain antibodies in the blood of multiple sclerosis patients by complement fixation tests.
    RASKIN N
    AMA Arch Neurol Psychiatry; 1955 Jun; 73(6):645-55. PubMed ID: 14375428
    [No Abstract]   [Full Text] [Related]  

  • 16. [Epitopes on myelin proteins recognized by autoantibodies present in multiple sclerosis patients].
    Jaśkiewicz E
    Postepy Hig Med Dosw (Online); 2004; 58():472-82. PubMed ID: 15765008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The peculiarities of the antibrain antibodies in multiple sclerosis and other diseases accompanied by myelin destruction.
    Gannushkina IV; Sukhorukova LI; Zavalishin IA
    Acta Neurol (Napoli); 1985; 7(3-4):323-7. PubMed ID: 4061144
    [No Abstract]   [Full Text] [Related]  

  • 18. [Significance of blood-brain barrier permeability for complement-fixing antibodies in the pathogenesis of disseminated sclerosis].
    Leonovich AL; Ziuzenkov VV; Sizonenko TP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(3):345-9. PubMed ID: 5027045
    [No Abstract]   [Full Text] [Related]  

  • 19. [Complement-fixing antibrain antibodies].
    Sazonova LV; Iavkin VM
    Vestn Dermatol Venerol; 1976 Jun; (6):26-30. PubMed ID: 1014835
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunologic differentiation of brain antigens in multiple sclerosis].
    Panov AG; Shamreĭ RK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(2):161-70. PubMed ID: 636708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.